Drug Topics publishes only print or online content that is not commercial or promotional in nature and that has not been published elsewhere. In the interest of transparency, Drug Topics will, as necessary, ask authors and sources to provide disclosures or conflict-of-interest statements, which will be published as appropriate to further the cause of information service to the pharmacy community.


One place in our magazine where your article might be used is as a regular news story, such as coverage of a clinical meeting. Freelancers who are covering a meeting must contact the Editor first to ascertain interest.


Other venues are the opinion columns "In My View," "Viewpoint," and "Student Corner," and the guest editorial, "Dispensed as Written." These columns are written by pharmacists or student pharmacists who have professional experiences they wish to share or strong views on a given pharmacy-related subject that we deem of interest to our readers. These commentaries should be 600-650 words long and should be accompanied by a color head shot of the author. (The photo should be in .jpg format, 300 dpi resolution or higher, and 2 MB if possible.) We make no guarantees of publication; contact the Editor first to ascertain interest.


Finally, you can express your views in the form of a letter to the Editor, which will be considered for publication on our Letters page. Letters should be concise. Please include your name, title, city/state, e-mail address, and date of the issue you are referencing. We will not consider letters without this information. Please send letters to:


Julia Talsma, Editor-in-Chief

Drug Topics

Advanstar Communications

24950 Country Club Blvd., Suite 200

North Olmsted, Ohio 44070


E-mail address: [email protected]


Correspondence may be edited for length and clarity.


We provide payment only for articles we have commissioned. There is no remuneration for unsolicited submissions, such as Viewpoint.


Drug Topics is a top-ranked pharmacy resource for community and health-system pharmacists. Since 1856, readers have turned to Drug Topics for coverage of issues and trends important to the practice of pharmacy. The journal also offers a free peer-reviewed CPE activity through its partnership with the University of Connecticut School of Pharmacy. For inquiries about contributing to Drug Topics, please query the editorial director at [email protected]


Electronic submissions are preferred. Please submit electronic submissions to [email protected]

If you don't have computer capability, fax your article to 440-891-2714. For further information, contact the Editor-in-Chief at 440-891-2792.